Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Mutations in certain receptors can cause diseases and offer new treatment options.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Estrogen therapy can reduce skin aging but has cancer risks.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.